Leerink: Medivation Buyout 'Inevitable,' AstraZeneca And AbbVie Most Likely Buyers

By: via Benzinga
Leerink’s Geoffrey C. Porges believes that acquirer interest in Medivation Inc (NASDAQ: MDVN) and the appreciation in the stock ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.